Opening a medspa requires capital deployment across six major categories, each with distinct variables that shift based on geography, licensure model, and equipment strategy. Unlike a retail business with predictable buildout costs, a medspa's startup spend hinges on clinical scope (injectables-only vs. energy devices vs. surgical), regulatory pathway (medical director vs. independent RN/PA ownership), and whether you're leasing or financing equipment. Understanding the true cost structure—not vendor-supplied fantasy budgets—lets you model break-even patient volume, negotiate with lenders, and avoid the common trap of underfunding working capital. This page walks the real numbers.

Facility Buildout and Lease

Medspa real estate typically ranges from 1,200 to 2,500 sq ft depending on service mix. Rent in tier-1 markets (NYC, LA, Miami, Chicago) runs $3,000–$8,000/month; tier-2 cities (Austin, Nashville, Denver) $1,500–$3,500/month; tier-3 $800–$1,500/month. Buildout—HVAC, electrical (critical for RF and laser), plumbing, treatment rooms, waiting area, staff areas—costs $75–$150/sq ft in most markets, totaling $90,000–$375,000 upfront. Medical-grade flooring, infection-control infrastructure, and proper lighting add cost. Lease terms typically run 5–10 years; negotiate a 6–12 month rent abatement during buildout. Many practices secure a 3–5 year lease with renewal options to preserve flexibility. Budget 3–6 months for permitting and construction before opening.

Equipment: Injectables vs. Energy Devices

Injectables-only practices (neuromodulator and filler) require minimal capital: treatment chairs ($2,000–$5,000 each, typically 2–3), a refrigerator for product storage ($500–$1,500), and basic supplies. Total: $10,000–$20,000. Energy-device practices drive much higher CapEx. A single RF microneedling system (InMode Morpheus8, Cutera Xeo) costs $80,000–$150,000; laser platforms (Cutera CoolGlide, Synergist) $60,000–$200,000; cryolipolysis (CoolSculpting, Evolus Emsculpt Neo) $50,000–$100,000. Most practices acquire 2–3 modalities to diversify revenue. Leasing vs. buying: leases run 36–60 months at 8–12% of purchase price monthly, preserving cash but locking you into vendor relationships and upgrade constraints. Buying requires capital but offers tax depreciation (5–7 year MACRS) and long-term cost advantage if patient volume sustains. Budget $150,000–$400,000 for a mixed-modality practice; $50,000–$100,000 for injectables-focused.

Licensing, Compliance, and Professional Fees

Regulatory costs vary sharply by state and ownership model. Physician-owned practices: medical license verification, DEA registration (if prescribing), state medical board application ($500–$2,000). RN/PA-owned practices under physician supervision: medical director agreement (typically $2,000–$10,000/year retainer or per-injection fee), state nursing/PA board application ($300–$1,500), supervision documentation setup. MSO/DSO structures: corporate practice of medicine compliance review ($3,000–$8,000), operating agreement drafting ($2,000–$5,000). All practices need business licensing ($200–$1,000), liability insurance ($3,000–$8,000/year for $1M/$2M coverage), and product liability ($1,000–$3,000/year). Compliance infrastructure—EMR with audit trails, consent forms, adverse-event tracking—adds $2,000–$5,000 in setup and $500–$1,500/month in software. State-specific requirements (e.g., New York's strict delegation rules, California's scope-of-practice nuance) can add $5,000–$15,000 in legal fees to structure correctly.

Initial Inventory: Toxin, Filler, and Consumables

Product cost is a variable expense, not startup capital, but initial stocking requires working capital. A typical 2-provider practice stocks 50–100 units of neuromodulator (Botox, Dysport, Xeomin) and 20–40 syringes of filler (Juvederm, Restylane, Radiesse) to launch. At wholesale (via Alle, Aspire, Evolus Rewards programs): neuromodulator runs $8–$12/unit; filler $80–$150/syringe depending on product and volume tier. Initial inventory: $5,000–$15,000. Consumables—needles, syringes, topicals, numbing cream, post-care products—add $2,000–$5,000. Many practices negotiate 30–60 day payment terms with distributors, reducing immediate cash outlay. Manufacturer loyalty programs (Alle's tiered rebates, Aspire's volume incentives) improve margins after 90 days of consistent ordering, but don't assume rebates in month one.

Staffing and Payroll Setup

Payroll is the largest recurring cost but requires upfront investment in hiring and training. A 2-provider practice typically needs: 1–2 injectors (RN, PA, or MD), 1–2 estheticians (for prep, post-care, retail), 1 front-desk/admin. Salaries: injectors $60,000–$90,000/year base plus commission (10–20% of service revenue); estheticians $35,000–$50,000/year; admin $30,000–$40,000/year. Recruiting, background checks, and onboarding: $2,000–$5,000 per hire. Payroll processing, workers' comp insurance, and benefits setup: $1,500–$3,000 upfront. Many practices hire part-time or contract injectors initially (1099 at 40–50% of service revenue) to reduce fixed overhead until patient volume justifies full-time staff. Budget 3–6 months of payroll ($30,000–$60,000) in working capital before opening.

Marketing and Patient Acquisition

First-year marketing spend typically ranges $10,000–$40,000 depending on market saturation and strategy. Digital: Google Ads and Instagram ($2,000–$8,000/month), SEO/website ($1,500–$3,000 one-time plus $500–$1,000/month), email platform ($200–$500/month). Offline: local partnerships with dermatologists or plastic surgeons ($1,000–$5,000 in co-marketing), grand-opening events ($2,000–$5,000), print collateral ($1,000–$2,000). Influencer/referral: micro-influencer seeding ($2,000–$5,000), patient referral incentives ($500–$2,000 budget). Most practices allocate 5–10% of projected first-year revenue to marketing; a practice projecting $300,000 year-one revenue should budget $15,000–$30,000. Expect 60–90 days before patient flow stabilizes; many practices underestimate this lag and run out of working capital.

Bottom line

A realistic medspa startup requires $200,000–$600,000 in capital depending on scope; injectables-only at the low end, mixed-modality energy devices at the high end—and don't underestimate working capital for 6 months of payroll and marketing before break-even.